​

Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Verrica Pharmaceuticals Ownership Summary

Verrica Pharmaceuticals is owned by 25.66% institutional investors, 51.84% insiders, and 22.50% retail investors. Blackrock is the largest institutional shareholder, holding 2.43% of VRCA shares. Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund, with 0.96% of its assets in Verrica Pharmaceuticals shares.

VRCA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVerrica Pharmaceuticals25.66%51.84%22.50%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock1.13M2.43%$8.23M
Vanguard group138.19K1.46%$1.15M
Jane street group101.72K1.07%$845.31K
Millennium management395.65K0.76%$174.96K
Geode capital management67.66K0.71%$562.39K
Sovran advisors32.66K0.34%$248.53K
Renaissance26.40K0.28%$219.38K
Mariner24.54K0.26%$203.96K
Morgan stanley22.01K0.23%$182.89K
Goldman sachs group18.62K0.20%$154.74K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Legacy trust17.23K0.03%$143.22K
Sovran advisors32.66K0.02%$248.53K
Beck mack & oliver12.00K0.00%$99.72K
Fortitude family office608.000.00%$5.05K
New england capital financial advisors200.000.00%$1.66K
Hrt financial lp17.36K0.00%$144.00K
Capital analysts1.50K0.00%$12.00K
Renaissance26.40K0.00%$219.38K
Salomon & ludwin290.000.00%$2.57K
Mariner24.54K0.00%$203.96K

Top Buyers

HolderShares% AssetsChange
Millennium management395.65K0.00%395.65K
Jane street group101.72K0.00%101.72K
Goldman sachs group18.62K-18.62K
Hrt financial lp17.36K0.00%17.36K
Legacy trust17.23K0.03%17.23K

Top Sellers

HolderShares% AssetsChange
Caligan partners lp---9.24M
Armistice capital---8.88M
Avoro capital advisors---4.00M
Perceptive advisors---3.25M
Boothbay fund management---2.81M

New Positions

HolderShares% AssetsChangeValue
Jane street group101.72K0.00%101.72K$845.31K
Goldman sachs group18.62K-18.62K$154.74K
Hrt financial lp17.36K0.00%17.36K$144.00K
Legacy trust17.23K0.03%17.23K$143.22K
Aqr capital management14.44K-14.44K$10.11K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
True wealth design-8.00
Srs capital advisors-9.00
Sterling capital management-19.00
Farther finance advisors-31.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025333.13%2,435,253-1.39%253.79%18157.14%7-70.83%
Sep 30, 20251-98.08%568-100.00%-0.00%--100.00%--100.00%
Jun 30, 202552-27.78%24,696,020-16.20%262.70%23-41.03%20100.00%
Mar 31, 20253-96.25%9,407,623-68.57%180.44%2-95.12%--100.00%
Dec 31, 202477-3.75%29,394,92197.36%626.20%39-9.30%1812.50%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Invesco Dorsey Wright SmallCap Momt ETF409.00K0.96%-
Vanguard US Total Market Shares ETF815.89K0.89%-
Fidelity Select Biotechnology517.63K0.57%-112.24K
iShares Russell 2000 ETF520.96K0.56%-
Simplify Propel Opportunities ETF200.00K0.44%-
Fidelity Small Cap Index385.38K0.42%-
Small Cap Core Equity Composite174.70K0.41%-
DWS Small Cap Core S174.70K0.41%-
Vanguard Institutional Extnd Mkt Idx Tr57.78K0.36%-
Vanguard Total Stock Mkt Idx Inv52.82K0.33%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 25, 2025Rosenberg Noah L. CMOBuy$3.72K
Nov 25, 2025Rosenberg Noah L. CMOBuy$10.00K
Nov 25, 2025Kirby John J. Interim CFOBuy$15.00K
Nov 25, 2025Kirby John J. Interim CFOBuy$5.58K
Nov 25, 2025Zawitz David Chief Operating OfficerBuy$42.42K

Insider Transactions Trends

DateBuySell
2025 Q412-
2025 Q2--
2025 Q1-1
2024 Q412-
2024 Q3-18

VRCA Ownership FAQ

Who Owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals shareholders are primarily institutional investors at 25.66%, followed by 51.84% insiders and 22.50% retail investors. The average institutional ownership in Verrica Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Verrica Pharmaceuticals falls below.

Who owns the most shares of Verrica Pharmaceuticals?

Verrica Pharmaceuticals’s largest shareholders are Blackrock (1.13M shares, 2.43%), Vanguard group (138.19K shares, 1.46%), and Jane street group (101.72K shares, 1.07%). Together, they hold 4.96% of Verrica Pharmaceuticals’s total shares outstanding.

Does Blackrock own Verrica Pharmaceuticals?

Yes, BlackRock owns 2.43% of Verrica Pharmaceuticals, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.23M$. In the last quarter, BlackRock increased its holdings by 15.08K shares, a 1.35% change.

Who is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Legacy trust is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 17.23K Verrica Pharmaceuticals shares, valued at 143.22K$.

Who is the top mutual fund holder of Verrica Pharmaceuticals shares?

Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund holder of Verrica Pharmaceuticals shares, with 0.96% of its total shares outstanding invested in 409K Verrica Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools